Study on active components and targets of Ginseng in Prevention and treatment of PTSD based on Network Pharmacology
10.3969/j.issn.1001-1978.2021.08.022
- Author:
Zhong-Li WANG
1
;
Li-Jun GAN
1
;
Xiu-Xiu LIU
1
;
Xiu-Li LI
1
;
Ben-Yi YI
1
Author Information
1. School of Nursing, Jiujiang University
- Publication Type:Journal Article
- Keywords:
data mining;
drug target;
enrichment analysis;
ginseng;
network pharmacology;
post-traumatic stress disorder
- From:
Chinese Pharmacological Bulletin
2021;37(8):1159-1163
- CountryChina
- Language:Chinese
-
Abstract:
Aim To obtain the active components and targets of ginseng in the prevention and treatment of traumatic stress disorder(PTSD) through the method of network pharmacology. Methods The active components and target information of ginseng with medicinal value were obtained by TCMSP research platform, and the gene information closely related to the pathogenesis of PTSD was obtained by searching GeneCard and OMIM database. The two were matched to obtain the medicinal components and target genes of ginseng in the prevention and treatment of PTSD. The drug-dis- ease-target network diagram was drawn by R and Perl computer languages, and the target genes were analyzed by PPI network analysis, gene ontology ( GO ) and signal transduction pathway ( KEGG) enrichment analysis. Results According to the general pharmacological research methods of traditional Chinese medi cine, the screening parameters of active components were set, and nine kinds of high value medicinal ingredients of Panax ginseng were obtained. There was a drug-target relationship between the nine medicinal components and sixteen target genes related to PTSD disease. Through PPI, GO and KEGG analysis, it was found that the target genes were mainly enriched in physiological functions such as neurotransmitters, syn-aptic plasticity, ion channels and so on. Conclusions Ginseng has the pharmacological effect of preventing and treating PTSD, which may play a role in regulating the metabolism and receptor activity of monoamine neurotransmitters.
